Soluble Levels of Receptor for Advanced Glycation Endproducts (sRAGE) and Coronary Artery Disease: The Next C-Reactive Protein?

Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/01.atv.0000164804.05324.8b
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Receptor for Advanced Glycation Endproducts (RAGE)

Science-Business eXchange
2012English

C-Reactive Protein and Coronary Artery Disease

Japanese Heart Journal
2002English

High Sensitivity C-Reactive Protein Levels Across Spectrum and Severity of Coronary Artery Disease

Journal of Clinical and Scientific Research
2012English

Elevated Plasma and Alveolar Levels of Soluble Receptor for Advanced Glycation Endproducts Are Associated With Severity of Lung Dysfunction in ARDS Patients

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2010English

Relationship Between Soluble Receptor for Advanced Glycation End Products (sRAGE), Body Composition and Fat Distribution in Healthy Women

European Journal of Nutrition
MedicineNutritionDietetics
2016English

Study of C-Reactive Protein and Some Small Antioxidant Molecule Levels in Coronary Artery Disease (Cad)

Journal of Al-Nahrain University Science
2010English

Advanced Glycation Endproducts in Multiple Sclerosis

English

Elevated Serum C-Reactive Protein Levels Predict Cardiovascular Events in the Japanese Coronary Artery Disease (JCAD) Study

Circulation Journal
MedicineCardiovascular MedicineCardiology
2009English

The Expression of the Receptor for Advanced Glycation Endproducts (RAGE) Is Permissive for Early Pancreatic Neoplasia

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy